Fig. 7
Influence of Ad-MSC administration route on the engraftment of purified HSCs. Donor cell engraftment (fold increase) in the peripheral blood of recipient mice intravenously infused with 1500 LSK cells (white bars), with intravenous co-infusion of 106 Ad-MSCs (gray bars), or with intraperitoneal injection of 106 (striped bars) or 2×106 (dark gray bars) Ad-MSCs. Bars represent standard error of the mean. ***P ≤ 0.001. Ad-MSC adipose tissue-derived mesenchymal stem cell, HSC hematopoietic stem cell, IP intraperitoneal injection, IV intravenous infusion, LSK lineage− Sca-1+ cKit+, ns non-significant difference